Audio By Carbonatix
AstraZeneca Plc said a “careful” review of all available data of the more than 17 million people in the European Union and the U.K. it has vaccinated against so far against Covid-19 shows no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia.
The company says it is continually monitoring the safety of its vaccine.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
Dr. Dre joins Forbes billionaires list as second-richest hip-hop artist with $1 billion fortune
26 minutes -
Oil rises as investors remain wary US-Iran ceasefire will open supply flow
54 minutes -
Eight appear in court as police intensify crackdown on illicit drugs in Tamale
3 hours -
Motorist remanded in custody for hitting four-year-old girl
3 hours -
Mobile money vendor robbed at Ziope
3 hours -
Benin’s Finance Minister Wadagni seeks his own mandate in election
4 hours -
GNFS retrieves body of unidentified man from Asylum Down drain
4 hours -
CAF’s Motsepe to visit both Senegal and Morocco amid AFCON fallout
4 hours -
Edmond Boateng takes up secretary role at Honorary Consular Corps of Ghana
4 hours -
Armed men kill 20 and abduct others in northwestern Nigeria villages
4 hours -
Gambia appoints British barrister to prosecute gruesome Jammeh-era crimes
4 hours -
Girl group Flo on entering into their ‘bombastic, confident, strong’ era
5 hours -
Germany suspends military approval for long stays abroad for men under 45
5 hours -
Liverpool face uphill Champions League task after PSG thrashing in Paris
5 hours -
‘Ketamine Queen’ sentenced to 15 years in Matthew Perry overdose death
5 hours